A diagnostic confusion between Serotonin syndrome and Neuroleptic malignant syndrome
- PMID: 33008703
- PMCID: PMC7320697
- DOI: 10.1016/j.ajem.2020.06.046
A diagnostic confusion between Serotonin syndrome and Neuroleptic malignant syndrome
Conflict of interest statement
Declaration of competing interest None to declare.
Comment in
-
The authors' response: A diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome.Am J Emerg Med. 2021 May;43:274. doi: 10.1016/j.ajem.2020.06.048. Epub 2020 Jun 25. Am J Emerg Med. 2021. PMID: 32622686 Free PMC article. No abstract available.
Comment on
-
Neuroleptic malignant syndrome in patients with COVID-19.Am J Emerg Med. 2020 Oct;38(10):2243.e1-2243.e3. doi: 10.1016/j.ajem.2020.05.042. Epub 2020 May 22. Am J Emerg Med. 2020. PMID: 32473756 Free PMC article.
References
-
- Perry P.J., Wilborn C.A. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Ann Clin Psychiatry. May 1 2012;24(2):155–162. - PubMed
-
- Gillman P.K. The serotonin syndrome and its treatment. J Psychopharmacol. 1999;13(1):100–109. - PubMed
-
- Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991;148(6):705–713. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
